Gleba et al. had already indicated that not the level of VDR but its polymorphic variations, especially Fok1, might be a factor that plays a role in the sensitivity of different cell lines (human leukemia and lymphoma cell lines) to VitD3 [36]. This evidence concerns the gene VDR and lymphoma.